Study shows immune molecule may play key role in the progression of ALS

Mayo Clinic researchers and collaborators have identified a protein expressed by immune cells that may play a key role in the development of  amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig's disease. The team also found that an immunomodulatory treatment that blocks the protein was able to restore motor function in preclinical models. The findings suggest that the protein, known as α5 integrin (pronounced alpha 5 integri n), is a potential therapeutic target for ALS. The study was…
Source: News from Mayo Clinic - Category: Databases & Libraries Source Type: news